PIM
DRUG

Platinum Investment Management’s Bright Minds Biosciences DRUG Stock Holding History

Platinum Investment Management’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.4M Sell
19,127
-2,603
-12% -$210K 0.35% 72
2025
Q4 		$1.7M Sell
21,730
-6,578
-23% -$440K 0.39% 70
2025
Q3 		$1.72M Hold
28,308
– – 0.11% 70
2025
Q2 		$739K Hold
28,308
– – 0.05% 82
2025
Q1 		$1.02M Buy
+28,308
New +$1.04M 0.06% 71

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Platinum Investment Management's DRUG Position: Q1 2026 in Review

Platinum Investment Management reduced its Bright Minds Biosciences (DRUG) stake by 12% in Q1 2026, selling an estimated $210K and leaving 19,127 shares worth $1.4M. The position accounts for 0.35% of the portfolio, ranked #72.

Platinum Investment Management first reported a position in DRUG in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.72M in Q3 2025. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Platinum Investment Management held 19,127 shares of Bright Minds Biosciences worth $1.4M as of Q1 2026.
  • Platinum Investment Management sold 2,603 Bright Minds Biosciences shares in Q1 2026, an estimated $210K.
  • Bright Minds Biosciences made up 0.35% of Platinum Investment Management's portfolio in Q1 2026, its #72 holding.
  • Platinum Investment Management first reported a position in Bright Minds Biosciences in Q1 2025 and has held it in 5 quarters since.
  • Platinum Investment Management's Bright Minds Biosciences position peaked at $1.72M in Q3 2025.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Platinum Investment Management's 13F filing for Q1 2026, filed 14 May 2026.